180 related articles for article (PubMed ID: 31376329)
1. Down-Regulation of miR-200c and Up-Regulation of miR-30c Target both Stemness and Metastasis Genes in Breast Cancer.
Rahimi M; Sharifi-Zarchi A; Zarghami N; Geranpayeh L; Ebrahimi M; Alizadeh E
Cell J; 2020 Jan; 21(4):467-478. PubMed ID: 31376329
[TBL] [Abstract][Full Text] [Related]
2. Essential role of miR-200c in regulating self-renewal of breast cancer stem cells and their counterparts of mammary epithelium.
Feng ZM; Qiu J; Chen XW; Liao RX; Liao XY; Zhang LP; Chen X; Li Y; Chen ZT; Sun JG
BMC Cancer; 2015 Sep; 15():645. PubMed ID: 26400441
[TBL] [Abstract][Full Text] [Related]
3. An integrated analysis to predict micro-RNAs targeting both stemness and metastasis in breast cancer stem cells.
Rahimi M; Sharifi-Zarchi A; Firouzi J; Azimi M; Zarghami N; Alizadeh E; Ebrahimi M
J Cell Mol Med; 2019 Apr; 23(4):2442-2456. PubMed ID: 30710426
[TBL] [Abstract][Full Text] [Related]
4. An integrated analysis to predict micro-RNAs targeting both stemness and metastasis in human gastric cancer.
Azimi M; Totonchi M; Rahimi M; Firouzi J; Sahranavard P; Emami Razavi A; Memari F; Kamali F; Ebrahimi M
J Gastroenterol Hepatol; 2021 Feb; 36(2):436-445. PubMed ID: 32633423
[TBL] [Abstract][Full Text] [Related]
5. Up-regulation of miR-210 induced by a hypoxic microenvironment promotes breast cancer stem cells metastasis, proliferation, and self-renewal by targeting E-cadherin.
Tang T; Yang Z; Zhu Q; Wu Y; Sun K; Alahdal M; Zhang Y; Xing Y; Shen Y; Xia T; Xi T; Pan Y; Jin L
FASEB J; 2018 Sep; ():fj201801013R. PubMed ID: 30188754
[TBL] [Abstract][Full Text] [Related]
6. miR-200c/141 Regulates Breast Cancer Stem Cell Heterogeneity via Targeting HIPK1/β-Catenin Axis.
Liu B; Du R; Zhou L; Xu J; Chen S; Chen J; Yang X; Liu DX; Shao ZM; Zhang L; Yu Z; Xie N; Guan JL; Liu S
Theranostics; 2018; 8(21):5801-5813. PubMed ID: 30613263
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-200c modulates epithelial-to-mesenchymal transition (EMT) in human colorectal cancer metastasis.
Hur K; Toiyama Y; Takahashi M; Balaguer F; Nagasaka T; Koike J; Hemmi H; Koi M; Boland CR; Goel A
Gut; 2013 Sep; 62(9):1315-26. PubMed ID: 22735571
[TBL] [Abstract][Full Text] [Related]
8. miR-200c suppresses stemness and increases cellular sensitivity to trastuzumab in HER2+ breast cancer.
Tang H; Song C; Ye F; Gao G; Ou X; Zhang L; Xie X; Xie X
J Cell Mol Med; 2019 Dec; 23(12):8114-8127. PubMed ID: 31599500
[TBL] [Abstract][Full Text] [Related]
9. p53 regulates epithelial-mesenchymal transition and stem cell properties through modulating miRNAs.
Chang CJ; Chao CH; Xia W; Yang JY; Xiong Y; Li CW; Yu WH; Rehman SK; Hsu JL; Lee HH; Liu M; Chen CT; Yu D; Hung MC
Nat Cell Biol; 2011 Mar; 13(3):317-23. PubMed ID: 21336307
[TBL] [Abstract][Full Text] [Related]
10. LncRNA XIST/miR-200c regulates the stemness properties and tumourigenicity of human bladder cancer stem cell-like cells.
Xu R; Zhu X; Chen F; Huang C; Ai K; Wu H; Zhang L; Zhao X
Cancer Cell Int; 2018; 18():41. PubMed ID: 29559853
[TBL] [Abstract][Full Text] [Related]
11. miR-200c, a tumor suppressor that modulate the expression of cancer stem cells markers and epithelial-mesenchymal transition in colorectal cancer.
Karimi Dermani F; Amini R; Saidijam M; Najafi R
J Cell Biochem; 2018 Jul; 119(7):6288-6295. PubMed ID: 29663476
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the expressions pattern of miR-10b, 21, 200c, 373 and 520c to find the correlation between epithelial-to-mesenchymal transition and melanoma stem cell potential in isolated cancer stem cells.
Fomeshi MR; Ebrahimi M; Mowla SJ; Khosravani P; Firouzi J; Khayatzadeh H
Cell Mol Biol Lett; 2015 Sep; 20(3):448-65. PubMed ID: 26208390
[TBL] [Abstract][Full Text] [Related]
13. Mutant p53 Attenuates Oxidative Phosphorylation and Facilitates Cancer Stemness through Downregulating miR-200c-PCK2 Axis in Basal-Like Breast Cancer.
Chao CH; Wang CY; Wang CH; Chen TW; Hsu HY; Huang HW; Li CW; Mai RT
Mol Cancer Res; 2021 Nov; 19(11):1900-1916. PubMed ID: 34312289
[TBL] [Abstract][Full Text] [Related]
14. Morphological and molecular characteristics of spheroid formation in HT-29 and Caco-2 colorectal cancer cell lines.
Gheytanchi E; Naseri M; Karimi-Busheri F; Atyabi F; Mirsharif ES; Bozorgmehr M; Ghods R; Madjd Z
Cancer Cell Int; 2021 Apr; 21(1):204. PubMed ID: 33849536
[TBL] [Abstract][Full Text] [Related]
15. Withaferin A mediated changes of miRNA expression in breast cancer-derived mammospheres.
Prajapati KS; Shuaib M; Gupta S; Kumar S
Mol Carcinog; 2022 Sep; 61(9):876-889. PubMed ID: 35770722
[TBL] [Abstract][Full Text] [Related]
16. miR-10b expression in breast cancer stem cells supports self-renewal through negative PTEN regulation and sustained AKT activation.
Bahena-Ocampo I; Espinosa M; Ceballos-Cancino G; Lizarraga F; Campos-Arroyo D; Schwarz A; Maldonado V; Melendez-Zajgla J; Garcia‐Lopez P
EMBO Rep; 2016 May; 17(5):648-58. PubMed ID: 27113763
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-200c overexpression inhibits tumorigenicity and metastasis of CD117+CD44+ ovarian cancer stem cells by regulating epithelial-mesenchymal transition.
Chen D; Zhang Y; Wang J; Chen J; Yang C; Cai K; Wang X; Shi F; Dou J
J Ovarian Res; 2013 Jul; 6(1):50. PubMed ID: 23842108
[TBL] [Abstract][Full Text] [Related]
18. MiR-221 promotes stemness of breast cancer cells by targeting DNMT3b.
Roscigno G; Quintavalle C; Donnarumma E; Puoti I; Diaz-Lagares A; Iaboni M; Fiore D; Russo V; Todaro M; Romano G; Thomas R; Cortino G; Gaggianesi M; Esteller M; Croce CM; Condorelli G
Oncotarget; 2016 Jan; 7(1):580-92. PubMed ID: 26556862
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-200c overexpression plays an inhibitory role in human pancreatic cancer stem cells by regulating epithelial-mesenchymal transition.
Ma C; Ding YC; Yu W; Wang Q; Meng B; Huang T
Minerva Med; 2015 Aug; 106(4):193-202. PubMed ID: 26081037
[TBL] [Abstract][Full Text] [Related]
20. Suppression of miR-204 enables oral squamous cell carcinomas to promote cancer stemness, EMT traits, and lymph node metastasis.
Yu CC; Chen PN; Peng CY; Yu CH; Chou MY
Oncotarget; 2016 Apr; 7(15):20180-92. PubMed ID: 26933999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
